全文获取类型
收费全文 | 850篇 |
免费 | 85篇 |
国内免费 | 20篇 |
专业分类
儿科学 | 20篇 |
妇产科学 | 13篇 |
基础医学 | 52篇 |
口腔科学 | 2篇 |
临床医学 | 81篇 |
内科学 | 133篇 |
皮肤病学 | 272篇 |
神经病学 | 5篇 |
特种医学 | 9篇 |
外科学 | 79篇 |
综合类 | 102篇 |
预防医学 | 16篇 |
眼科学 | 1篇 |
药学 | 78篇 |
2篇 | |
中国医学 | 77篇 |
肿瘤学 | 13篇 |
出版年
2024年 | 4篇 |
2023年 | 26篇 |
2022年 | 25篇 |
2021年 | 49篇 |
2020年 | 51篇 |
2019年 | 51篇 |
2018年 | 44篇 |
2017年 | 43篇 |
2016年 | 35篇 |
2015年 | 23篇 |
2014年 | 67篇 |
2013年 | 65篇 |
2012年 | 41篇 |
2011年 | 55篇 |
2010年 | 47篇 |
2009年 | 47篇 |
2008年 | 32篇 |
2007年 | 29篇 |
2006年 | 26篇 |
2005年 | 27篇 |
2004年 | 24篇 |
2003年 | 18篇 |
2002年 | 18篇 |
2001年 | 9篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1995年 | 4篇 |
1994年 | 5篇 |
1993年 | 8篇 |
1992年 | 2篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 4篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1980年 | 1篇 |
1972年 | 1篇 |
排序方式: 共有955条查询结果,搜索用时 46 毫秒
1.
Thomas A. Luger Harald Gollnick Thomas Schwennesen Raphael Bextermller Siegfried Freytag Matthias Brutigam 《Journal der Deutschen Dermatologischen Gesellschaft》2007,5(10):908-914
Background: Pimecrolimus cream 1% has proven to be well‐tolerated and effective in controlled clinical studies in patients with atopic dermatitis (AD). In a 15‐week patient self‐observation study, safety and efficacy was investigated in the daily practice. Patients and methods: 3502 patients with AD (mean age 26.2 ± 18 years, 62% female) received pimecrolimus cream 1% from 810 physicians in the German Federal Republic.The severity of the disease was assessed at baseline, two times during the 15‐week observation period and at the end of treatment.Patients recorded daily the degree of erythema and pruritus. At the end of treatment, safety and efficacy were assessed by the physician based on patient's daily records and by the patient. Results: The percentage of patients with severe or massive AD decreased from 25% to 7%, whereas the percentage of patients without or with mild symptoms increased from 9% to 55%.The efficacy of treatment was rated by physicians as good or very good in 83.5% of cases and by 79% of patients.At baseline 35% of the patients were free of flares as compared to 75% at the end of therapy. Disease control was better in patients who followed the recommended treatment algorithm for pimecrolimus cream.Tolerability was mostly rated as good or very good. Conclusion: Treatment with pimecrolimus cream 1% for patients with AD is well‐tolerated and effective in daily practice. 相似文献
2.
The effect of subhypnotic doses of propofol on intrathecal morphine-induced pruritus was studied in a prospective, randomly allocated, double-blind controlled trial. Fifty-eight women undergoing elective lower segment Caesarean section for a singleton fetus received spinal anaesthesia with 2.5 ml hyperbaric 0.5% bupivacaine and 0.2 mg of preservative-free morphine. They then received propofol 1 ml (10 mg) or Intralipid 1 ml (control group) intravenously after delivery. Pruritus was assessed using a five-point verbal rating scale at hourly intervals for 8 h. A second dose of their allocated treatment drug was administered at the first recording of significant pruritus. The pruritus score was reassessed after 5 min and the treatment was repeated if pruritus remained. There were no differences between the groups in the onset of pruritus or its successful treatment. No adverse side-effects were associated with this dose of propofol. There were no differences in the incidence of post-operative nausea and vomiting between the two groups. Subhypnotic propofol is not an effective treatment for intrathecal morphine-induced pruritus in women following Caesarean section. 相似文献
3.
4.
Milana Popović-Rolović Mirjana Kostić Miodrag Sindjić Olga Jovanović Amira Peco-Antić Divna Kruščić 《Pediatric nephrology (Berlin, Germany)》1993,7(4):396-400
We report the clinical and morphological features of a distinctive hepatorenal disorder in four patients and review the five similar patients in the literature. The main clinical characteristics were early onset of cholestatic liver disease and progressive tubulointerstitial nephritis leading to renal death in early childhood. Liver histology showed disturbed architecture with nodular and acinar formations and portal fibrosis and bile duct proliferation. Histological abnormalities in the kidney were severe interstitial fibrosis and tubular atrophy and dilatation, while the typical features of nephronophthisis were lacking. These clinical and morphological characteristics distinguish our patients from the majority described, as having nephronophthisis and congenital hepatic fibrosis or any other known syndrome with concomitant hepatorenel involvement. We suggest that the association of cholestatic liver disease and progressive tubulointerstitial nephritis represents a new syndrome. 相似文献
5.
百特药液治疗外耳道瘙痒症的临床研究 总被引:2,自引:0,他引:2
目的:筛选治疗外耳道瘫痒症的理想药物,以期从根本上治疗该病。方法:采用分组用药,并按双盲法观察疗效。试用药物为百特药液、1.0%酚甘油、氯霉素眼药水,4%硼酸酒精和生理盐水(对照)。结果:四种药物中百特药液对外耳道瘙痒症的治疗效果显著,近期治愈率达84%。结论:百特药液是临床上治疗外耳道瘙痒症大有希望的药物,值得在临床上推广试用。 相似文献
6.
Martin J. White Edward J. Berghausen Stephen W. Dumont Kentaro Tsueda Julia A. Schroeder Robert L. Vogel Michael F. Heine Kou Chu Huang 《Journal canadien d'anesthésie》1992,39(6):576-582
Respiratory effects, nausea, somnolence, and pruritus were compared during a 48-hr period of continuous epidural morphine (n = 34) and fentanyl (n = 32) infusion in 66 patients following elective total replacement of the hip or knee joint. Respiratory effects were assessed by PaCO2. Side effects were assessed by visual analogue scale and considered to be present when the score was above 30. Assessment was made at preoperative visits then 3, 6, 12, 24, 36, and 48 hr after the epidural injection. The bolus dose and subsequent infusion rate were 3,900 +/- 1,300 micrograms and 427 +/- 213 micrograms.hr-1 for morphine, and 85 +/- 46 micrograms and 56 +/- 27 micrograms.hr-1 for fentanyl. Pain relief was similar in both groups. In the morphine group, PaCO2 elevation and nausea occurred over a period of more than 12 hr (P less than 0.05). In the fentanyl group, there was no PaCO2 change, and nausea was confined to the first few hours. Nausea was more severe (P less than 0.01 at six hours and more frequent (24 hr cumulative incidence, 53 vs 28%, P less than 0.05) in the morphine group. Somnolence was prominent within several hours in two-thirds of patients in both groups. Somnolence continued to decline thereafter in the morphine group, but it was demonstrable in approximately half of the patients throughout the second day in the fentanyl group. The incidence was higher in the fentanyl group at the 48th hr (P less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
7.
8.
局部涂抹木犀草素抑制小鼠干燥性皮肤瘙痒 总被引:1,自引:0,他引:1
目的:对木犀草素对小鼠干燥性皮炎的作用进行了评价。方法:用丙酮和乙醚的混合液(1:1)局部敷于ICR小鼠皮肤造成干燥性皮炎模型,造模期间,小鼠皮肤局部应用木犀草素(2,20,100μg/site),5天后观察45min内小鼠的自发瘙瘁行为,检测造模处皮肤的PGE2含量。此外,我们还对木犀草素体外对compound 48/80(50μg/ml)引起的大鼠腹腔肥大细胞脱颗粒情况进行了评价。结果:木犀草素能够显著减少干燥性皮炎引起的小鼠的自主瘙痒行为,降低病变皮肤中的PGE2含量,并能有效抑制compound 48/80(50μg/ml)引起的大鼠腹腔肥大细胞脱颗粒。结论:木犀草素能有效减轻小鼠干燥性皮炎的瘙痒症状,其作用可能是通过对肥大细胞脱颗粒及局部炎症的抑制来实现的。 相似文献
9.
Sixty patients in early labour were randomly allocated to one of three groups. The control group received intrathecal fentanyl 25 microg, the ropivacaine group received intrathecal fentanyl 25 microg and ropivacaine 2.5 mg while the bupivacaine group received intrathecal fentanyl 25 microg and bupivacaine 2.5 mg. The incidence of pruritus was 100% in controls, compared with 85% in the ropivacaine group (not significant) and 75% in the bupivacaine group (p = 0.003). The severity of pruritus was significantly less in the ropivacaine (p = 0.006) and bupivacaine (p = 0.001) groups. Most patients developed pruritus by 30 min. Pruritus above the abdomen was not reduced in patients receiving local anaesthetics. There were no significant differences in the mean pain visual analogue score, systolic blood pressure, maternal heart rate and upper level of reduced pin-prick sensation in the first 30 min. Intrathecal ropivacaine and, more so, intrathecal bupivacaine reduce the incidence and severity of pruritus from intrathecal fentanyl for labour analgesia. 相似文献
10.
A Ayhan E S Guvendag Guven S Guven M Sakinci T Kucukali 《International journal of gynaecology and obstetrics》2006,95(3):278-283
OBJECTIVE: To evaluate symptomatic response and recurrence rates of graduated topical fluorinated corticosteroid in patients with vulvar squamous cell hyperplasia. METHODS: Nine hundred seventy-six patients with biopsy-proven vulvar squamous cell hyperplasia from 1990 to 2003 were reviewed in this retrospective study. All patients were treated with graduated topical fluorinated corticosteroid. Data were obtained from hospital records. Symptomatic remission and recurrence rates were noted following six months local therapy. RESULTS: The mean age was 42.55+/-10.93 (15-85). The remission rate was 93.8% in six months. The remission rate was non-significantly higher in postmenopausal patients than that in their premenopausal counterpart (94.9% vs 93.0%, p=0.15). The disease recurred in 6.9% of patients. Of the patients that suffered recurrence 47.5% had persistent disease initially. The patients with following factors older ages (>40 years), postmenopausal period had significantly higher recurrence rates. Four patients with recurrent disease and six patients with persistent disease in the form of vulvar intraepithelial neoplasia I-II or atypical squamous hyperplasia, were treated with skinning vulvectomy. CONCLUSION: Corticosteroid in the treatment of vulvar squamous cell hyperplasia yielded excellent response rates. In the evaluation of patients without symptomatic relief, the first step should be a vulvar biopsy to exclude the presence of atypical components. 相似文献